Costs for treating latent MDR-TB infection, point estimates and ranges for sensitivity analyses.

*Average cost of routine monitoring and evaluation for mild toxicity assuming 40% of patients will require monthly monitoring of hepatic enzymes (100% for patients on pyrazinamide) and 1.4% will have toxicity severe enough to require a physician evaluation but that does not limit treatment.
**Medicare cost assumed for 15 minutes of physician time for 40% of patients.
***North Carolina Public Health Pharmacy Data.